Editorials
Covid-19 related hospital admissions in the United States: needs and outcomes
BMJ 2020; 369 doi: https://doi.org/10.1136/bmj.m2082 (Published 27 May 2020) Cite this as: BMJ 2020;369:m2082Read our latest coverage of the coronavirus pandemic
Linked Research
Factors associated with hospital admission and critical illness among 5279 people with covid-19
Linked Research
Incidence, clinical outcomes, and transmission dynamics of severe covid-19 in California and Washington
Re: Covid-19 related hospital admissions in the United States: needs and outcomes
Dear Editor
I note the recent paper by Brownstein et al, 'A Novel Approach to Treating COVID-19 Using Nutritional and Oxidative Therapies'. From the Abstract [1]:
"Conclusion: At present, there is no published cure, treatment, or preventive for COVID-19 except for a recent report on dexamethasone for seriously ill patients. A novel treatment program combining nutritional and oxidative therapies was shown to successfully treat the signs and symptoms of 100% of 107 patients diagnosed with COVID-19.
Each patient was treated with an individualized plan consisting of a combination of oral, IV, IM, and nebulized nutritional and oxidative therapies which resulted in zero deaths and recovery from COVID-19."
[1] David Brownstein, Richard Ng, Robert Rowen, Jennie-Dare Drummond, Taylor Eason, Hailey Brownstein, and Jessica Brownstein, 'A Novel Approach to Treating COVID-19 Using Nutritional and Oxidative Therapies', Science, Public Health Policy, and The Law Volume 2:4-22 July, 2020 Clinical and Translational Research, https://cf5e727d-d02d-4d71-89ff-9fe2d3ad957f.filesusr.com/ugd/adf864_cc5...
Competing interests: AgeofAutism.com, an on-line daily journal, concerns itself with the potential environmental sources for the proliferation of autism, neurological impairment, immune dysfunction and chronic disease. I receive no payment as UK Editor